Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605491852 | ||
| 003 | CHVBK | ||
| 005 | 20210128100512.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150401xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10147-015-0795-6 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10147-015-0795-6 | ||
| 100 | 1 | |a Iwase |D Hirotaka |u Department of Breast and Endocrine Surgery, Kumamoto University, 1-1-1 Honjo, Chuo-ku, 860-8556, Kumamoto, Japan |4 aut | |
| 245 | 1 | 0 | |a Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor |h [Elektronische Daten] |c [Hirotaka Iwase] |
| 540 | |a Japan Society of Clinical Oncology, 2015 | ||
| 773 | 0 | |t International Journal of Clinical Oncology |d Springer Japan |g 20/2(2015-04-01), 249-252 |x 1341-9625 |q 20:2<249 |1 2015 |2 20 |o 10147 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10147-015-0795-6 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a review-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10147-015-0795-6 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 100 |E 1- |a Iwase |D Hirotaka |u Department of Breast and Endocrine Surgery, Kumamoto University, 1-1-1 Honjo, Chuo-ku, 860-8556, Kumamoto, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t International Journal of Clinical Oncology |d Springer Japan |g 20/2(2015-04-01), 249-252 |x 1341-9625 |q 20:2<249 |1 2015 |2 20 |o 10147 | ||